Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bamford, C. R.
Right arrow Articles by Laguna, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bamford, C. R.
Right arrow Articles by Laguna, J. F.
NEUROLOGY 1978;28:119-124
© 1978 American Academy of Neurology

Uveitis, perivenous sheathing and multiple sclerosis

Colin R. Bamford, M.D., James P. Ganley, M.D., William A. Sibley, M.D. and Jose F. Laguna, M.D.

Departments of Neurology (Drs. Bamford, Sibley, and Laguna) and the Division of Ophthalmology, Department of Surgery (Dr. Ganley), University of Arizona Health Sciences Center, Tucson, Arizona.

Pars planitis (peripheral uveitis) and perivenous sheathing are two ocular phenomena associated with multiple sclerosis (MS). A total of 163 ocular examinations were performed on 127 MS patients at the university of Arizona Health Sciences Center. The prevalence of pars planitis in our study is lower (2.4 percent) than found by others, but significantly higher than its occurrence in the general population. We attribute our lower prevalence to the method of ocular examination (scleral depression and indirect ophthalmoscopy), as well as to firmly defined criteria necessary to make the diagnosis of pars planitis. The incidence of perivenous sheathing (11 percent) reported by us is consistent with the experience of others; however, this finding was noted more frequently in patients with the progressive form of MS. No perivenous sheathing was found to develop within the first few weeks following 31 exacerbations, and no association was identified between its presence and the severity of neurologic disability.

Reprint requests should be addressed to Dr. Bamford, Department of Neurology, University of Arizona Health Sciences Center, 1501 N. Campbell Ave., Tucson, AZ 85724.

This research was supported in part by grant No. RG1132-A-1 from the National MS Society.

Accepted for publication May 8. 1978.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by AAN Enterprises, Inc.